TXM13 human melanoma cells: A novel source for the inhibition kinetics of human tyrosinase and for screening whitening agents

Biochemistry and Cell Biology

Volumn 84, Issue 1, 2006, Pages 112-116

  Park, Yong Doo ^a   Kim, So Yeon ^b   Lyou, You Jeong ^b   Lee, Dong Youn ^a   Yang, Jun Mo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Human tyrosinase; Pigment cell; TXM13; Whitening agent

Indexed keywords

CELL CULTURE; DISEASES; ENZYMES; GENES; PIGMENTS;

HUMAN TYROSINASE; PIGMENT CELL; TXM13; WHITENING AGENT;

CELLS;

DITHIOGLYCERINE; GLYCEROL DERIVATIVE; MONOPHENOL MONOOXYGENASE; OXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DEPIGMENTATION; DRUG INHIBITION; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN CELL; KINETICS; MELANOGENESIS; MELANOMA;

ENZYME INHIBITORS; GLYCEROL; HUMANS; HYPOPIGMENTATION; KINETICS; MELANOMA; MONOPHENOL MONOOXYGENASE; PHENOTYPE; SKIN PIGMENTATION;

EID: 33645394824     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o05-151     Document Type: Article

References (10)

1. Branza-Nichita, N., Negroiu, G., Petrescu, A.J., Garman, E.F., Platt, P.M., Wormald, M.R. et al. 2000. Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control. J. Biol. Chem. 275: 8169-8175.
2. Chen, Q.X., and Kubo, I. 2002. Kinetics of mushroom tyrosinase inhibition by quercetin. J. Agric. Food Chem. 50: 4108-4112.
3. Hearing, V.J., and Jimenez, M. 1987. Mammalian tyrosinase, the critical regulatory control point in melanocyte pigmentation. Int. J. Biochem. 19: 1141-1147.
4. Jimbow, K., Park, J.S., Kato, F., Hirosaki, K., Toyofuku, K., Hua, C., and Yamashita, T. 2000. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigm. Cell Res. 13: 222-229.
5. Kim, Y.M., Yun, J., Lee, C.K., Lee, H., Min, K.R., and Kim, Y. 2002. Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 277: 16340-16344.
6. Sánchez-Ferrer, Á, Rodríguez-López, J.N., García-Cánovas, F., and García-Carmona, F. 1995. Tyrosinase: a comprehensive review of its mechanism. Biochim. Biophys. Acta, 1247: 1-11.
7. Sarangarajan, R., and Boissy, R.E. 2001. Tyrp1 and oculocutaneous albinism type 3. Pigm. Cell Res. 14: 437-444.
8. Toyofuku, K., Wada, I., Valencia, J.C., Kushimoto, T., Ferrans, V.J., and Hearing, V.J. 2001. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB J. 15: 2149-2161.
9. Újvári, A., Aron, R., Eisenhaure, T., Cheng, E., Parag, H.A., Smicun, Y., Halaban, R., and Hebert, D.N. 2001. Translation rate of human tyrosinase determines its N-linked glycosylation level. J. Biol. Chem. 276: 5924-5931.
10. Yu, B., and Swi Chang, T.M. 2004. In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanoma. Melanoma Res. 14: 197-202.